tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ADMA is currently covered by 3 analysts with an average price target of $25.61. This is a potential upside of $7.66 (42.67%) from yesterday's end of day stock price of $17.95.
ADMA Biologics's activity chart (see below) currently has 74 price targets and 57 ratings on display. The stock rating distribution of ADMA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 80.32% with an average time for these price targets to be met of 1081 days.
Highest price target for ADMA is $35, Lowest price target is $25, average price target is $30.67.
Most recent stock forecast was given by ELLIOT WILBUR from on 08-May-2025. First documented stock forecast 09-Sep-2015.
Currently out of the existing stock ratings of ADMA, 3 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 14-Nov-2017
$32
$14.05 (78.27%)
$25
8 months 3 days ago
(08-May-2025)
5/7 (71.43%)
$10.8 (50.94%)
632
Buy
Since 09-Jul-2019
$35
$17.05 (94.99%)
$14
8 months 3 days ago
(08-May-2025)
8/9 (88.89%)
$13.8 (65.09%)
520
Buy
Since 10-Nov-2021
$25
$7.05 (39.28%)
$20
10 months 7 days ago
(04-Mar-2025)
8/9 (88.89%)
$7.99 (46.97%)
138
Buy
Since 16-Mar-2020
$26
$8.05 (44.85%)
$18
1 years 2 months 3 days ago
(08-Nov-2024)
14/15 (93.33%)
$3.38 (14.94%)
298
Buy
Since 13-Jul-2018
$4
$-13.95 (-77.72%)
$7
5 years 2 months 5 days ago
(06-Nov-2020)
6/6 (100%)
$2.09 (109.42%)
1736
What is ADMA (ADMA Biologics) average time for price targets to be met?
Which analyst has the current highest performing score on ADMA (ADMA Biologics) with a proven track record?
Which analyst has the current lower performing score on ADMA (ADMA Biologics) with a proven track record?
Which analyst has the most public recommendations on ADMA (ADMA Biologics)?
Which analyst is the currently most bullish on ADMA (ADMA Biologics)?
Which analyst is the currently most reserved on ADMA (ADMA Biologics)?
